# Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation

> **NCT00673296** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 6 (actual)

## Conditions studied

- Diabetic Retinopathy With Premacular Hemorrhage

## Interventions

- **DRUG:** Intravitreal Bevacizumab

## Key facts

- **NCT ID:** NCT00673296
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2008-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673296, "Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00673296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*